Medinex Limited

OTX

SGXE82839874

Business Support Services

Delayed Singapore S.E. Other stock markets 03:44:15 2024-04-29 am EDT			5-day change	1st Jan Change
0.178 ^SGD	-11.00%		-11.00%	-11.00%

Jan. 17	Medinex Chief Integration Officer Reappointed as Financial Controller	MT
Jan. 16	Medinex Limited Announces Re-Designation of Low Siam Kiang from Chief Integration Officer to Financial Controller	CI

Samintharaj Kumar acquired an unknown majority stake in Nuffield Dental Holdings from Medinex Limited for SGD 1.3 million.

July 06, 2023

Samintharaj Kumar acquired an unknown majority stake in Nuffield Dental Holdings from Medinex Limited (Catalist:OTX) for SGD 1.3 million on July 7, 2023. Medinex intends to utilise the net proceeds for general working capital requirements and new business expansion.

Samintharaj Kumar completed the acquisition of an unknown majority stake in Nuffield Dental Holdings from Medinex Limited (Catalist:OTX) on July 7, 2023.

Latest news about Medinex Limited

Medinex Chief Integration Officer Reappointed as Financial Controller	Jan. 16	MT
Medinex Limited Announces Re-Designation of Low Siam Kiang from Chief Integration Officer to Financial Controller	Jan. 16	CI
Medinex Finance Chief to Step Down in January 2024	Dec. 18	MT
Medinex Limited Announces Cessation of Liew Wei Chun as Chief Financial Officer	Dec. 18	CI
Medinex Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 14	CI
Medinex Reduces Investments in Quoted Securities	23-10-11	MT
Medinex Limited Approves Final Dividend for the Year Ended March 31, 2023	23-08-21	CI
Singapore Stocks Start Week in Green; Dasin Retail Trust Shares Slip 2% on Posting Wider Losses in H2 2022	23-07-10	MT
Medinex Disposes of Shareholding in Singaporean Medical Support Services Provider	23-07-09	MT
Samintharaj Kumar acquired an unknown majority stake in Nuffield Dental Holdings from Medinex Limited for SGD 1.3 million.	23-07-06	CI
Medinex Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-30	CI
Medinex Limited Recommends Final Dividend for Fiscal Year Ended 31 March 2023	23-05-30	CI
Medinex's Attributable Profit Plummets 68% in April-September	22-11-15	MT
Medinex Limited Announces Interim Dividend for the Financial Year Ending 31 March 2023, Payable on 18 January 2023	22-11-14	CI
Medinex Limited Reports Earnings Results for the Half Year Ended September 30, 2022	22-11-14	CI
Medinex Responds to Singapore Exchange Queries Regarding Employee Charged by Health Sciences Authority	22-09-09	MT
Medinex Limited Approves Final Dividend Tax Exempt One-Tier Dividend for the Financial Year Ended March 31, 2022	22-07-27	CI
Medinex Issues Over 1 Million Consideration Shares for Ark Leadership & Learning Acquisition	22-07-20	MT
Medinex Limited Proposes Final Dividend (Tax-Exempt One-Tier) for the Financial Year Ended 31 March 2022, Payable on 30 September 2022	22-07-05	CI
Medinex's H2 Attributable Net Profit Decreases 64% Despite Higher Revenue	22-05-31	MT
Medinex Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-05-30	CI
Medinex Redesignates Financial Controller to Chief Integration Officer	22-05-25	MT
Medinex Limited Announces Redesignation of Low Siam Kiang from Financial Controller to Chief Integration Officer	22-05-25	CI
Medinex Appoints New CFO	22-05-25	MT
Medinex Limited Appoints Liew Wei Chun as Chief Financial Officer	22-05-24	CI

Chart Medinex Limited

Duration

Period

More charts

Company Profile

Medinex Limited is an investment holding company. The principal activities of its are providing business support services, providing medical support services and providing pharmaceutical services. Its segments include Medical support services, Business support services, Pharmaceutical and Medical services. The Medical support services segment provides professional services to clients in primary and secondary healthcare sectors, comprising general practitioners and specialists. The Business support services segment provides professional services to customer bases who are outside of the healthcare industry. The Pharmaceutical services segment provides distribution of medical and pharmaceutical products to clinics located in Singapore. The Medical services segment provides x-rays, pre-employment check-ups and health screening in clinics located in Singapore. Its subsidiaries include Medinex Corporate Services Pte. Ltd., Medinex Healthcare Services Pte. Ltd. and Nex Healthcare Pte. Ltd.

Sector

Business Support Services

Calendar

2024-05-27 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Business Support Services

	1st Jan change	Capi.
MEDINEX LIMITED	-11.00%	17.37M
CINTAS CORPORATION	+9.24%	67.56B
JACOBS SOLUTIONS INC.	+10.58%	18.33B
RB GLOBAL, INC.	+7.01%	13.47B
BUREAU VERITAS SA	+19.90%	13.36B
INTERTEK GROUP PLC	+16.44%	9.99B
TELEPERFORMANCE SE	-35.27%	5.82B
GENPACT LIMITED	-11.44%	5.6B
MAXIMUS, INC.	-4.27%	4.94B
EXLSERVICE HOLDINGS, INC.	-6.00%	4.89B